| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/02/2007 | CN1313159C Hab18G/CD147 molecule small segment interfering RNA medicine and application thereof |
| 05/02/2007 | CN1313158C Method of promoting nucleic acid transfer |
| 05/02/2007 | CN1313151C Preparation of high-performance noncellular vaccine and usage |
| 05/02/2007 | CN1313150C Therapeutic agent for treating autoimmune diseases |
| 05/02/2007 | CN1313149C Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313145C Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 05/02/2007 | CN1313107C Medicine for treating tumor |
| 05/02/2007 | CN1313104C Anticancer medicine composition with synergistic bupleurum root and polymyxin |
| 05/02/2007 | CN1313101C Chinese medicine for strengthening antitumour thorapeutic effect of glossy ganoderma spore oil |
| 05/02/2007 | CN1313100C Antitumour Chinese medicine preparation |
| 05/02/2007 | CN1313099C Carbon gas gel transfusion agent, its preparing method and its use |
| 05/02/2007 | CN1313094C Use of ZD6474 in preparation of drug for treating cancer in human treated by ionising radiation |
| 05/02/2007 | CN1313093C New application of berbamine as intracorporeal antitumor drug |
| 05/02/2007 | CN1313091C Vitamin C composition |
| 05/02/2007 | CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
| 05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
| 05/01/2007 | USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening |
| 05/01/2007 | US7211680 (5Z,7E,22E)-(1S,3R,24R)-25-phenyl-26,27-cyclo-9,10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; treating hyperprolifierative diseases of the skin, tumor diseases and precancerous stages, auto-immune diseases, rejection reactions in the case of autologous, allogenic or xenogenic transplants, AIDS |
| 05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
| 05/01/2007 | US7211648 Gag-peptide complex |
| 05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
| 05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 05/01/2007 | US7211597 Antiinflammatory agents; rheumatic diseases; anticancer agents |
| 05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
| 05/01/2007 | US7211583 Substituted azaindole as drugs and enzyme inhibitors |
| 05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
| 05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
| 05/01/2007 | US7211570 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV") |
| 05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
| 05/01/2007 | US7211562 cytotoxic agents followed by a heat shock protein 90 inhibitor, has a synergistic effect on the growth inhibition of cells; destroying cells having a cell proliferative disorder with wild-type retinoblastoma gene |
| 05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
| 05/01/2007 | US7211411 Human papilloma virus treatment |
| 05/01/2007 | US7211404 Liver engrafting cells, assays, and uses thereof |
| 05/01/2007 | US7211398 Human genes and gene expression products: II |
| 05/01/2007 | US7211387 DNA molecule encoding a variant paraoxonase and uses thereof |
| 05/01/2007 | US7211276 Method for preventing ulceration or irritation of mucosa |
| 05/01/2007 | US7211258 Protein A compositions and methods of use |
| 05/01/2007 | US7211257 Methods for inducing apoptosis in ovarian carcinoma cells using an anti-regeneration and tolerance factor antibody |
| 05/01/2007 | US7211252 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/01/2007 | US7211251 Antibodies to transferrin receptor-like proteins |
| 05/01/2007 | US7211250 Method and composition for inhibiting cancer cell growth |
| 05/01/2007 | US7211246 Compositions comprising oestrone-3-0-sulphamate and trail (TNF-related apoptosis inducing ligand) |
| 05/01/2007 | CA2392917C Pin1 as a marker for abnormal cell growth |
| 05/01/2007 | CA2366679C Stabilized oral pharmaceutical composition containing iodide and iodate and method |
| 05/01/2007 | CA2320706C 20-hete antagonists and agonists |
| 05/01/2007 | CA2301590C 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 05/01/2007 | CA2296036C Dolastatin 15 derivatives |
| 05/01/2007 | CA2283587C Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles |
| 05/01/2007 | CA2268434C Mycophenolic bisphosphonate derivatives and their preparation from tetraphosphonate bicyclic trisanhydrides |
| 05/01/2007 | CA2227205C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 05/01/2007 | CA2206748C Salts of ethyl 3-(2-(4-(4-(amino-imino-methyl)phenyl)-4-methyl-2,5-dioxoimidazolidin-1-yl)acetylamino)-3-phenylpropionate |
| 05/01/2007 | CA2185394C Biotinderivate |
| 05/01/2007 | CA2120303C Cyclic adhesion inhibitors |
| 04/26/2007 | WO2007048070A2 Pyrrolo-pyridine derivatives for the treatment of cancer diseases |
| 04/26/2007 | WO2007047315A1 Amifostine dihydrate crystalline composition |
| 04/26/2007 | WO2007046729A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
| 04/26/2007 | WO2007046524A1 EXTRACT LIQUID CONTAINING β-CRYPTOXANTHIN INGREDIENT, AND FOOD OR BEVERAGE AND SOAP OR COSMETIC EACH CONTAINING THE EXTRACT LIQUID |
| 04/26/2007 | WO2007046456A1 Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 04/26/2007 | WO2007046392A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 04/26/2007 | WO2007045844A1 Benzamide compounds useful as histone deacetylase inhibitors |
| 04/26/2007 | WO2007045758A1 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof |
| 04/26/2007 | WO2007045389A2 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma |
| 04/26/2007 | WO2007045096A1 Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands |
| 04/26/2007 | WO2007045027A1 Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 04/26/2007 | WO2007023382A3 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 04/26/2007 | WO2007022813A3 A METHOD FOR PREPARING A STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES OF TNFα AND A CARRIER PROTEIN |
| 04/26/2007 | WO2007020277A3 Condensed pyrimidine derivatives as inhibitors of foic acid-dependent enzymes |
| 04/26/2007 | WO2007014839A3 Cathepsin k inhibitors |
| 04/26/2007 | WO2007004060A3 Cytokine receptor modulators and uses thereof |
| 04/26/2007 | WO2007001839A3 4-anilino-3-quinolinecarbonitriles for the treatment of cancer |
| 04/26/2007 | WO2006136606A3 Oxindole derivatives |
| 04/26/2007 | WO2006131833A3 New hybrid oligomers. their preparation process and pharmaceutical compositions containing them |
| 04/26/2007 | WO2006125815A3 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 04/26/2007 | WO2006125139A3 Therapeutic uses of kallikreins |
| 04/26/2007 | WO2006074451A9 Targeted chimeric molecules for cancer therapy |
| 04/26/2007 | WO2006053121A3 Imidazo[1 , 2-a] pyrazin-8-ylamines useful as modulators of kinase activity |
| 04/26/2007 | WO2006050930A3 Conjugates with enhanced cell uptake activity |
| 04/26/2007 | WO2006042724A3 Magnetic particles for therapy and diagnosis |
| 04/26/2007 | WO2006040569A8 Thiophene amide compounds for use in the treatment or prophylaxis of cancers |
| 04/26/2007 | WO2005115991A8 Anti-cytokine heterocyclic compounds |
| 04/26/2007 | WO2004069139A3 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 04/26/2007 | US20070093658 used for the treatment of a cancer in mammals; anticarnogenic or antitumor agents |
| 04/26/2007 | US20070093553 HMB compositions and uses thereof |
| 04/26/2007 | US20070093532 Benzimidazole carboxamides as raf kinase inhibitors |
| 04/26/2007 | US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies |
| 04/26/2007 | US20070093506 Inhibitors of tyrosine kinases |
| 04/26/2007 | US20070093482 Thieno-imino acid derivatives for use as matrix metalloproteinase inhibitors |
| 04/26/2007 | US20070093480 e.g. 2 {5,6-dimethoxy-1-[2-(4-methylpiperazin- 1 -yl)ethyl]-1H-indol-3 -yl}-1H-pyrrolo[2,3- b]pyridine; Insulin Growth Factor-1 (somatomedin) antagonist; antiproliferative, antitumor agent; solid tumor; prostate, lung and breast cancer |
| 04/26/2007 | US20070093479 6-chloro-N-(3,3-dimethylbutyl)-5-phenyl-1H-indazol-3-amine; for treating neurodegenerative diseases such as Alzheimer's, fronto-parietal dementia, Pick's disease, Parkinson's disease, type II diabetes, corticobasal degeneration, in which phosphorylation of the tau protein is observed |
| 04/26/2007 | US20070093472 1-[(4-Ethynylphenyl)]-2-[(phenyl)]-pyrrolidine-1,2-dicarboxamide derivatives as inhibitors of coagulation factors xa and viia for the treatment of thromboses |
| 04/26/2007 | US20070093445 RNA interference mediating small RNA molecules |
| 04/26/2007 | US20070093441 useful to efficiently induce self-specific immune responses; comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin |
| 04/26/2007 | US20070093435 Modulation of cell phenotype by inhibitory rna |
| 04/26/2007 | US20070093434 Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 04/26/2007 | US20070093422 Drug comprising synthetic peptide analogs for the treatment of cancer |
| 04/26/2007 | US20070093419 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |